Search Results 291-300 of 15109 for TNF
... tumor necrosis factor agents) with the exception of pre-phase treatment with prednisone up to 100 mg daily for 7 days (or equivalent corticosteroid dose) ...
... tumor necrosis factor agents) within 2 weeks prior to the first dose of study treatment; any other anti-cancer therapy, whether investigational or approved ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.
Nilufer Taner, M.D., Ph.D. Neurologist. Request an Appointment · Overview · News ...
... tumor necrosis factor-alpha in primary CNS lymphoma. Blood. 2019 Jul 18; 134 (3):252-262 Epub 2019 May 22. View PubMed; Conte GM, Altabella L, Castellano A ...
... TNF-alpha-antagonists, anti-integrin therapies, agents targeting IL-12 or IL-23, etc.). Known intolerance/allergic reaction to imipenem or metronidazole ...
This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.
Other immune mediating medications; for example, but not limited to, azathioprine, 6-mercaptopurine, cyclosporine, methotrexate, anti-TNF monoclonal ...
... TNF-α agents) within 2 weeks prior to initiation of study treatment or anticipation of need for systemic immunosuppressive medication during study treatment ...
Received CD20 inhibitor, anti-tumor necrosis factor treatment, abatacept, alemtuzumab, any other experimental or biological therapy, intravenous ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.